TY - JOUR
T1 - Striatal spreading depolarization
T2 - Possible implication in levodopa-induced dyskinetic-like behavior
AU - de Iure, Antonio
AU - Napolitano, Francesco
AU - Beck, Goichi
AU - Quiroga Varela, Ana
AU - Durante, Valentina
AU - Sciaccaluga, Miriam
AU - Mazzocchetti, Petra
AU - Megaro, Alfredo
AU - Tantucci, Michela
AU - Cardinale, Antonella
AU - Punzo, Daniela
AU - Mancini, Andrea
AU - Costa, Cinzia
AU - Ghiglieri, Veronica
AU - Tozzi, Alessandro
AU - Picconi, Barbara
AU - Papa, Stella M.
AU - Usiello, Alessandro
AU - Calabresi, Paolo
PY - 2019/1/1
Y1 - 2019/1/1
N2 - Objective: Spreading depolarization (SD) is a transient self-propagating wave of neuronal and glial depolarization coupled with large membrane ionic changes and a subsequent depression of neuronal activity. Spreading depolarization in the cortex is implicated in migraine, stroke, and epilepsy. Conversely, spreading depolarization in the striatum, a brain structure deeply involved in motor control and in Parkinson's disease (PD) pathophysiology, has been poorly investigated. Methods: We characterized the participation of glutamatergic and dopaminergic transmission in the induction of striatal spreading depolarization by using a novel approach combining optical imaging, measurements of endogenous DA levels, and pharmacological and molecular analyses. Results: We found that striatal spreading depolarization requires the concomitant activation of D1-like DA and N-methyl-d-aspartate receptors, and it is reduced in experimental PD. Chronic l-dopa treatment, inducing dyskinesia in the parkinsonian condition, increases the occurrence and speed of propagation of striatal spreading depolarization, which has a direct impact on one of the signaling pathways downstream from the activation of D1 receptors. Conclusion: Striatal spreading depolarization might contribute to abnormal basal ganglia activity in the dyskinetic condition and represents a possible therapeutic target.
AB - Objective: Spreading depolarization (SD) is a transient self-propagating wave of neuronal and glial depolarization coupled with large membrane ionic changes and a subsequent depression of neuronal activity. Spreading depolarization in the cortex is implicated in migraine, stroke, and epilepsy. Conversely, spreading depolarization in the striatum, a brain structure deeply involved in motor control and in Parkinson's disease (PD) pathophysiology, has been poorly investigated. Methods: We characterized the participation of glutamatergic and dopaminergic transmission in the induction of striatal spreading depolarization by using a novel approach combining optical imaging, measurements of endogenous DA levels, and pharmacological and molecular analyses. Results: We found that striatal spreading depolarization requires the concomitant activation of D1-like DA and N-methyl-d-aspartate receptors, and it is reduced in experimental PD. Chronic l-dopa treatment, inducing dyskinesia in the parkinsonian condition, increases the occurrence and speed of propagation of striatal spreading depolarization, which has a direct impact on one of the signaling pathways downstream from the activation of D1 receptors. Conclusion: Striatal spreading depolarization might contribute to abnormal basal ganglia activity in the dyskinetic condition and represents a possible therapeutic target.
KW - D1 like receptor
KW - LIDs
KW - Parkinson's disease
KW - Spreading depolarization
KW - Striatum
UR - http://www.scopus.com/inward/record.url?scp=85061453376&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85061453376&partnerID=8YFLogxK
U2 - 10.1002/mds.27632
DO - 10.1002/mds.27632
M3 - Article
AN - SCOPUS:85061453376
SN - 0885-3185
JO - Movement Disorders
JF - Movement Disorders
ER -